Risk of schizophrenia, schizoaffective, and bipolar disorders by migrant status, region of origin, and age-at-migration: a national cohort study of 1.8 million people.
Bipolar disorder
epidemiology
mania
migration
psychotic disorders
schizophrenia
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
pubmed:
6
12
2018
medline:
28
7
2020
entrez:
6
12
2018
Statut:
ppublish
Résumé
We assessed whether the risk of various psychotic disorders and non-psychotic bipolar disorder (including mania) varied by migrant status, a region of origin, or age-at-migration, hypothesizing that risk would only be elevated for psychotic disorders. We established a prospective cohort of 1 796 257 Swedish residents born between 1982 and 1996, followed from their 15th birthday, or immigration to Sweden after age 15, until diagnosis, emigration, death, or end of 2011. Cox proportional hazards models were used to model hazard ratios by migration-related factors, adjusted for covariates. All psychotic disorders were elevated among migrants and their children compared with Swedish-born individuals, including schizophrenia and schizoaffective disorder (adjusted hazard ratio [aHR]migrants: 2.20, 95% CI 1.96-2.47; aHRchildren : 2.00, 95% CI 1.79-2.25), affective psychotic disorders (aHRmigrant1.42, 95% CI 1.25-1.63; aHRchildren: 1.22 95% CI 1.07-1.40), and other non-affective psychotic disorders (aHRmigrant: 1.97, 95% CI 1.81-2.14; aHRchildren: 1.68, 95% CI 1.54-1.83). For all psychotic disorders, risks were generally highest in migrants from Africa (i.e. aHRschizophrenia: 5.24, 95% CI 4.26-6.45) and elevated at most ages-of-migration. By contrast, risk of non-psychotic bipolar disorders was lower for migrants (aHR: 0.58, 95% CI 0.52-0.64) overall, and across all ages-of-migration except infancy (aHR: 1.20; 95% CI 1.01-1.42), while risk for their children was similar to the Swedish-born population (aHR: 1.00, 95% CI 0.93-1.08). Increased risk of psychiatric disorders associated with migration and minority status may be specific to psychotic disorders, with exact risk dependent on the region of origin.
Sections du résumé
BACKGROUND
We assessed whether the risk of various psychotic disorders and non-psychotic bipolar disorder (including mania) varied by migrant status, a region of origin, or age-at-migration, hypothesizing that risk would only be elevated for psychotic disorders.
METHODS
We established a prospective cohort of 1 796 257 Swedish residents born between 1982 and 1996, followed from their 15th birthday, or immigration to Sweden after age 15, until diagnosis, emigration, death, or end of 2011. Cox proportional hazards models were used to model hazard ratios by migration-related factors, adjusted for covariates.
RESULTS
All psychotic disorders were elevated among migrants and their children compared with Swedish-born individuals, including schizophrenia and schizoaffective disorder (adjusted hazard ratio [aHR]migrants: 2.20, 95% CI 1.96-2.47; aHRchildren : 2.00, 95% CI 1.79-2.25), affective psychotic disorders (aHRmigrant1.42, 95% CI 1.25-1.63; aHRchildren: 1.22 95% CI 1.07-1.40), and other non-affective psychotic disorders (aHRmigrant: 1.97, 95% CI 1.81-2.14; aHRchildren: 1.68, 95% CI 1.54-1.83). For all psychotic disorders, risks were generally highest in migrants from Africa (i.e. aHRschizophrenia: 5.24, 95% CI 4.26-6.45) and elevated at most ages-of-migration. By contrast, risk of non-psychotic bipolar disorders was lower for migrants (aHR: 0.58, 95% CI 0.52-0.64) overall, and across all ages-of-migration except infancy (aHR: 1.20; 95% CI 1.01-1.42), while risk for their children was similar to the Swedish-born population (aHR: 1.00, 95% CI 0.93-1.08).
CONCLUSIONS
Increased risk of psychiatric disorders associated with migration and minority status may be specific to psychotic disorders, with exact risk dependent on the region of origin.
Identifiants
pubmed: 30514409
pii: S0033291718003227
doi: 10.1017/S0033291718003227
pmc: PMC6763532
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2354-2363Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Références
BMJ. 2016 Mar 15;352:i1030
pubmed: 26979256
Global Health. 2016 Aug 25;12(1):47
pubmed: 27558472
Br J Psychiatry. 1990 Sep;157:410-5
pubmed: 2245273
Br J Psychiatry. 2010 Feb;196(2):109-15
pubmed: 20118454
Psychol Med. 2009 Feb;39(2):199-209
pubmed: 18588739
Br J Psychiatry. 1999 Sep;175:283-5
pubmed: 10645332
Am J Psychiatry. 2005 Jan;162(1):12-24
pubmed: 15625195
Transl Psychiatry. 2015 Aug 18;5:e623
pubmed: 26285133
Am J Psychiatry. 2017 Feb 1;174(2):143-153
pubmed: 27771972
BMC Neurosci. 2012 Feb 15;13:18
pubmed: 22336227
Br J Psychiatry. 2007 Jan;190:6-10
pubmed: 17197650
Biol Psychiatry. 2007 Oct 15;62(8):910-6
pubmed: 17543288
Psychol Med. 2001 Feb;31(2):189-95
pubmed: 11232907
Schizophr Bull. 2006 Jul;32(3):405-8
pubmed: 16699062
Soc Psychiatry Psychiatr Epidemiol. 2002 Nov;37(11):527-31
pubmed: 12395142
Am J Psychiatry. 2002 Apr;159(4):669-71
pubmed: 11925311
Am J Psychiatry. 2003 Jan;160(1):13-23
pubmed: 12505794
Int J Soc Psychiatry. 2013 Jun;59(4):342-50
pubmed: 22392446
Am J Psychiatry. 2012 Oct;169(10):1117-8
pubmed: 23032390
Schizophr Res. 2010 Dec;124(1-3):240-1
pubmed: 20813502
Psychol Med. 2016 Mar;46(4):807-18
pubmed: 26621616
Arch Gen Psychiatry. 2008 Nov;65(11):1250-8
pubmed: 18981336
Br J Psychiatry. 2008 Jul;193(1):18-24
pubmed: 18700213
Psychol Med. 2015 Jan;45(2):381-94
pubmed: 25065268
World Psychiatry. 2017 Jun;16(2):119-120
pubmed: 28498570
Psychol Med. 2015 Mar;45(4):727-34
pubmed: 25084213
PLoS One. 2012;7(3):e31660
pubmed: 22457710
Eur Neuropsychopharmacol. 2008 Nov;18(11):787-93
pubmed: 18725178
Schizophr Res. 2004 Dec 1;71(2-3):405-16
pubmed: 15474912
CMAJ. 2015 Jun 16;187(9):E279-E286
pubmed: 25964387
Am J Psychiatry. 2013 Nov;170(11):1275-84
pubmed: 23771174
J Abnorm Child Psychol. 2008 Oct;36(7):1057-68
pubmed: 18427975
Arch Gen Psychiatry. 2006 Mar;63(3):250-8
pubmed: 16520429
Psychol Med. 2014 Dec;44(16):3481-90
pubmed: 25066605
Schizophr Res. 2013 Oct;150(1):205-10
pubmed: 23899998
J Clin Psychiatry. 2006;67 Suppl 9:3-8; discussion 36-42
pubmed: 16965182
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1011-22
pubmed: 24919446
Psychol Med. 2011 May;41(5):897-910
pubmed: 20663257
World J Psychiatry. 2014 Dec 22;4(4):133-40
pubmed: 25540728
Int J Epidemiol. 2007 Aug;36(4):703-7
pubmed: 17646185
Am J Psychiatry. 2011 Dec;168(12):1278-85
pubmed: 22193672
Schizophr Bull. 2016 May;42(3):712-22
pubmed: 26834027
Psychiatry. 1974 Nov;37(4):321-39
pubmed: 4427966
Psychol Med. 2006 Nov;36(11):1541-50
pubmed: 16938150
Curr Psychiatry Rep. 2000 Aug;2(4):286-90
pubmed: 11122970
JAMA Psychiatry. 2013 Apr;70(4):427-35
pubmed: 23446644
Psychol Med. 2017 Dec;47(16):2753-2766
pubmed: 28585513
Epidemiol Psychiatr Sci. 2017 Aug;26(4):358-363
pubmed: 28343462
Br J Psychiatry. 2005 Feb;186:126-31
pubmed: 15684235
Schizophr Bull. 2010 Jan;36(1):112-25
pubmed: 19767349
Schizophr Res. 2010 Jun;119(1-3):27-33
pubmed: 20332065
Trends Cogn Sci. 1999 Sep;3(9):337-344
pubmed: 10461196
Schizophr Bull. 2000;26(2):379-93
pubmed: 10885638
J Affect Disord. 2017 Mar 01;210:174-180
pubmed: 28049102
Am J Psychiatry. 2002 Dec;159(12):2027-35
pubmed: 12450952
Schizophr Bull. 2017 Oct 21;43(6):1251-1261
pubmed: 28521056